ROME, Nov 20 (Reuters) - Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government document sent to parliament showed.
Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.
Italy's cabinet authorised the transaction on Nov. 12 with some unspecified conditions, according to the document.
Announced in September, the deal is worth some 150 million euros ($158.48 million).
($1 = 0.9465 euros)
(Reporting by Giuseppe Fonte, Editing by Louise Heavens)
((giuseppe.fonte@thomsonreuters.com; +390680307711;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。